Guy Levy insider trades: Parabilis Medicines (PBLS) stock buys and sales
Trades on the price chart
Daily close, with an arrow on each day they bought or sold
Companies
Where Guy reports to the SEC
Open-market buys and sales
6 trades reported on SEC Form 4, newest first
| Date | Stock | Type | Shares | Price | Value | Holding | Reported |
|---|---|---|---|---|---|---|---|
| Jun 11, 2026 | PBLS | ↑ Buy | 500,000 | $20.00 | $10.0M | Indirect | Jun 29, 2026 (18d) |
| Aug 24, 2021 | BCAB | ↓ Sell | 546,709 | $39.65 | $21.7M | Indirect | Aug 26, 2021 (2d) |
| Jun 17, 2021 | BCAB | ↓ Sell | 400,000 | $39.16 | $15.7M | Indirect | Jun 21, 2021 (4d) |
| Dec 18, 2020 | BCAB | ↑ Buy | 1,388,890 | $18.00 | $25.0M | Indirect | Dec 22, 2020 (4d) |
| May 5, 2020 | LYRA | ↑ Buy | 155,000 | $16.00 | $2.5M | Indirect | May 15, 2020 (10d) |
| May 5, 2020 | LYRA | ↓ Sell | 16,909 | $16.00 | $271K | Indirect | May 15, 2020 (10d) |
Each row is one filing's trades in one stock, summed. Shares and prices are as filed, before any later stock split.
Other PBLS insiders
Open-market trades in the last 12 months
About Guy Levy's insider trades
Guy Levy is a 10% owner of Parabilis Medicines (PBLS). Since May 5, 2020, Guy has reported 3 open-market purchases worth $37.5M and 3 sales worth $37.6M on SEC Form 4. In the last 12 months: 1 buy ($10.0M).
Their filings also include conversions (3 filings), grants and awards (2 filings), option exercises (1 filing). These aren't open-market trades and aren't counted above.
How to read insider trades
Officers, directors and owners of more than 10% of a company must report trades in its stock on SEC Form 4, usually within two business days. Purchases with their own money are the stronger signal: insiders sell for many reasons (taxes, diversification, a house), but buy for one. See every PBLS insider trade, the latest insider trades across the market, or cluster buys, when several insiders buy the same stock within days.